Ujaas Energy Ltd
₹184.71
-2.08 (1.11%)
Fri, 06 Nov 2026, 03:18 pm
Ujaas Energy News
Ujaas Energy Q2FY27 PAT jumps 2878% YoY to ₹2.75 crore
Ujaas Energy reported a sharp rise in net profit for Q2FY27 driven by one-time recoveries. Revenue from operations grew 6.9% YoY, while other income surged due to bad debt recovery and arbitration awards.
30 Oct 2026
companies
Ujaas Energy Q1FY27: Profit up 31% YoY
Ujaas Energy reports Q1FY27 net profit of ₹325.07 lakh, a 31% YoY rise driven by significant other income from bad debt recovery and arbitration awards.
30 Jul 2026
companies
Ujaas Energy AGM outcome on July 14
Ujaas Energy Limited held its 27th AGM on July 14, 2026, approving financial statements and key resolutions. Shareholders authorized borrowing up to ₹1,000 crore.
14 Jul 2026
companies
Ujaas Energy FY26 results
Ujaas Energy reported a 64% decline in net profit to INR 316.26 lakh for FY26, with revenue dropping to INR 1,663.85 lakh.
22 Jun 2026
companies
Ujaas Energy board approves ₹1,000 crore borrowing
Ujaas Energy's board approved borrowing up to ₹1,000 Crores and reappointed key directors, including Mrs. Geeta Mundra as Chairman, subject to shareholder approval.
22 Jun 2026
companies
Market Current News
CONTINENTAL CONTROLS LTD.
Continental Controls rights issue oversubscribed
Continental Controls Limited completed its rights issue of 1.96 crore shares at ₹10 each. The issue was oversubscribed 112.75% and shares list on BSE on November 5, 2026.
05 Nov 2026
ipo
Jivial Industries Limited
Jivial Industries changes IPO machinery vendors
Jivial Industries Ltd approved partial vendor changes for three machinery sets in its IPO project. Costs and timelines remain unchanged despite the switch.
05 Nov 2026
ipo
Antala IPO Day 6: Subscribed 6.43x
Antala Industries IPO sees strong QIB demand at 66.72x on final day. Total subscription reaches 6.43x as Retail and NII interest picks up.
05 Nov 2026
ipo
IGL Spirits lists on BSE and NSE post-demerger
IGL Spirits Limited listed on BSE and NSE on November 4, 2026. The demerged entity reported FY26 revenue of ₹2,801 crore and EBITDA of ₹492 crore.
04 Nov 2026
ipo
Ennature Bio Pharma lists on NSE, BSE
Ennature Bio Pharma Limited listed on NSE and BSE on November 4, 2026. The biopharma division reported ₹246 crore revenue in FY26, driven by branded nutraceuticals.
04 Nov 2026
ipo